Save on this medicine
Other brands with the same active ingredient
These brands contain the same active ingredient (Oseltamivir). Same strength and form. Confirm the switch with your doctor or pharmacist.
Indications & Uses
Oseltamivir is indicated for:
Pharmacology
Oseltamivir is an ethyl ester prodrug that must undergo ester hydrolysis to convert into its active form, oseltamivir carboxylate. It is thought to work by inhibiting influenza virus neuraminidase, which may also alter the aggregation and release of virus particles.
Dosage Reference
Reference Information Only
Dosages shown are general references from official sources. Always consult your doctor or pharmacist for personalized dosing.
Adults:
Oseltamivir Phosphate can be taken with or without food, though taking it with food may improve tolerability for some patients. For treatment of influenza in adults and adolescents 13 years and older, the recommended oral dose is 75 mg twice daily for 5 days, and treatment should begin within 2 days of the onset of influenza symptoms. The safety and efficacy of Oseltamivir for prophylaxis of influenza in pediatric patients younger than 13 years of age have not been established. For prophylaxis of influenza in adults and adolescents 13 years and older following close contact with an infected individual, the recommended oral dose is 75 mg once daily for at least 7 days, with therapy beginning within 2 days of exposure. For prophylaxis during a community outbreak of influenza, the recommended dose is 75 mg once daily; safety and efficacy have been demonstrated for up to 6 weeks, and protection lasts for as long as dosing continues.
Side Effects
The most frequently reported adverse events are nausea and vomiting. These events are generally mild to moderate in degree and usually occur within the first 2 days of treatment. Additional adverse events reported in fewer than 1% of patients taking Tamiflu for treatment include unstable angina, anemia, pseudomembranous colitis, humerus fracture, pneumonia, pyrexia, and peritonsillar abscess.
Cautions & Contraindications
Warnings & Precautions
General: There is no evidence that Tamiflu Phosphate is effective against illness caused by agents other than influenza viruses Types A and B. The efficacy of Tamiflu Phosphate in patients who begin treatment more than 40 hours after symptom onset has not been established. Hepatic Impairment: The safety and pharmacokinetics of Tamiflu Phosphate in patients with hepatic impairment have not been evaluated. Renal Impairment: A dose adjustment is recommended for patients whose serum creatinine clearance is below 30 mL/min.
Contraindications
This product is not suitable for anyone known to be hypersensitive to any of its ingredients.
Pregnancy & Breastfeeding
Pregnancy Category C: Human data are insufficient to assess the risk Oseltamivir Phosphate poses to a pregnant woman or her developing fetus.
Nursing Mothers: It is not known whether oseltamivir or its active form, oseltamivir carboxylate, passes into human breast milk. For this reason, Oseltamivir Phosphate should be used by nursing mothers only if the potential benefit to the mother outweighs the potential risk to the breastfed infant.
⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.
Use in Special Populations
Geriatric Use
Clinical studies have established the safety of Oseltamivir Phosphate in older people.
Pediatric Use
The safety and efficacy of Oseltamivir Phosphate in children younger than 1 year of age have not been studied. For this reason, it is not indicated for either treatment or prophylaxis of influenza in children under 1 year.
Overdose
There's no reported experience of overdose with Oseltamivir so far. Single doses of up to 1000 mg have been linked with nausea and/or vomiting.
⚠️ In an emergency call 999 or go to the nearest hospital emergency department.
Storage
Keep oseltamivir at 25°C. Once the suspension has been reconstituted, store it between 2-8°C for up to 17 days, or at 25°C for up to 10 days. Do not freeze it.
Drug Interactions
Common questions about Oseltamivir 75 mg
What is Oseltamivir 75 mg Capsule?
Oseltamivir 75 mg Capsule is a medicine that contains Oseltamivir. It is made by Renata PLC. It belongs to the Respiratory viral infections (Influenza) group of medicines.
What is Oseltamivir used for?
Oseltamivir is used for: Viral Infection.
What are the side effects of Oseltamivir?
The most frequently reported adverse events are nausea and vomiting. These events are generally mild to moderate in degree and usually occur within the first 2 days of treatment.
Can I take Oseltamivir during pregnancy or while breastfeeding?
Pregnancy Category C: Human data are insufficient to assess the risk Oseltamivir Phosphate poses to a pregnant woman or her developing fetus. Nursing Mothers: It is not known whether oseltamivir or its active form, oseltamivir carboxylate, passes into human breast milk. Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.
What happens if I take too much Oseltamivir?
There's no reported experience of overdose with Oseltamivir so far. Single doses of up to 1000 mg have been linked with nausea and/or vomiting. In an emergency call 999 or go to the nearest hospital emergency department.
How should I store Oseltamivir?
Keep oseltamivir at 25°C. Once the suspension has been reconstituted, store it between 2-8°C for up to 17 days, or at 25°C for up to 10 days.
Do I need a prescription for Oseltamivir?
Oseltamivir is a prescription (Rx) medicine. Take it as your doctor advises.